Supplementary Table S2 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Year: 2026
Type: supplementary-materials
Abstract: Mutect2 called and validated variants for each subject and each tumor region from whole exome sequencing data
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7124729076
Cites:
Cited by:
Related to: